About

Atomwise is at the forefront of integrating deep learning into the preclinical drug discovery process, with its proprietary AtomNet® technology. This leading-edge approach not only speeds up the discovery of small molecule medicines but also enhances the accuracy and diversity of drug candidates. Working at this company offers the opportunity to be part of a dynamic team that is addressing critical needs in medical treatment across hundreds of unique disease targets, supported by substantial investment from top venture capital firms.